Acute Estimated Glomerular Filtration Rate Decline After Initiation of Therapies That Slow Kidney Disease Progression: Clinical Practice Implications

Further Publications Urology

Sex Differences in Mortality and Receipt of Kidney Replacement Therapy Among Adults With Stage 5 Chronic Kidney Disease

JAMA Intern Med

Chan C, Sawhney S, Ahmed SB, Dumanski SM, Quinn RR, Lam NN, James MT, Ravani P, Liu P

doi: 10.1001/jamainternmed.2025.5979

Further Publications Urology

Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review

Adv Ther

Wanner C, Zhao MH, Amin AN, De Nicola L, Sauer AJ, Allum AM, Aranda U, Nam YS, Butler J

doi: 10.1007/s12325-025-03228-1

Further Publications Urology

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

Lancet

Heerspink HJL, Cardona JF, Jolly S, Pergola PE, de Sousa-Amorim E, Eriksson AL, Fredholm M, Gasparyan SB, Guzman NJ, Hartleib-Geschwindner J, Jiang Y, Leonsson-Zachrisson M, Mark PB, MIRO-CKD study investigators

doi: 10.1016/S0140-6736(25)02014-8

Further Publications Urology

Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Practical Approach to Screening and Management

Mayo Clin Proc

Borghol AH, Alkhatib B, Zayat R, Ravikumar NPG, Munairdjy Debeh FG, Ghanem A, Mina J, Mao MA, Dahl NK, Hickson LJ, Aslam N, Torres VE, Brown RD Jr, Tawk RG, Chebib FT

doi: 10.1016/j.mayocp.2025.02.003

Further Publications Urology

Chronic kidney disease

Lancet

Herrington WG, Judge PK, Grams ME, Wanner C

doi: 10.1016/S0140-6736(25)01942-7

Further Publications Urology

Autosomal dominant polycystic kidney disease

Lancet

Ong ACM, Carriazo S, Ma BM, Torra R, Pei Y

doi: 10.1016/S0140-6736(26)00046-2

Further Publications Urology

System Preparedness for Rising Kidney Replacement Therapy Demand: Late-Stage CKD Drives Costs, Healthcare Resource Utilisation and Environmental Impact in Switzerland

Adv Ther

Campbell-James T, Buff S, Nanchen G, Hall A, Rosemann T, Nicholson L, Priest S, Zara A, Hubbert L, Vecchio Rodriguez C, Wharton G, Pruijm M

doi: 10.1007/s12325-026-03519-1

Further Publications Urology

Long-term adverse effects of modern Wilms tumour therapies: implications for monitoring

Nat Rev Urol

Spreafico F, Gattuso G, Podda MG, Nigro O, Colombo V, Vennarini S, Mastrangelo A, Filippi F, Montini G, Massimino M, Terenziani M

doi: 10.1038/s41585-026-01126-x

Further Publications Urology

Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan

Adv Ther

Nangaku M, Sasaki K, Bi J, Ueta K, Nishimura K, Hashimoto T, Hata M

doi: 10.1007/s12325-025-03272-x

Related content

Sex Differences in Mortality and Receipt of Kidney Replacement Therapy Among Adults With Stage 5 Chronic Kidney Disease

Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Practical Approach to Screening and Management

Chronic kidney disease

Autosomal dominant polycystic kidney disease

System Preparedness for Rising Kidney Replacement Therapy Demand: Late-Stage CKD Drives Costs, Healthcare Resource Utilisation and Environmental Impact in Switzerland

Long-term adverse effects of modern Wilms tumour therapies: implications for monitoring

Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan